U.S. FDA approved first biosimilar to treat Multiple Sclerosis
On Aug. 24, 2023, the U.S. Food and Drug Administration approved Sandoz’s Tyruko (natalizumab-sztn), the first biosimilar to…
Parkinson’s disease gene variant found in study of some people of African ancestry
On Aug. 23, 2023, a gene variant found almost exclusively in the genomes of people of African ancestry…
CDC reported risk assessment summary for SARS CoV-2 sublineage BA.2.86
On Aug. 23, 2023, the CDC announced it had detected a new SARS-CoV-2 variant labeled BA.2.86. CDC was…
Scientists released the first complete sequence of a human Y chromosome
On Aug. 23. 2023, researchers co-led by University of California, Santa Cruz Assistant Professor of Biomolecular Engineering Karen…
Aspirin can help prevent a second heart attack, but most don’t take it
On Aug. 22, 2023, a study led by researchers at Washington University School of Medicine in St. Louis…
Project NextGen awarded over $1.4 billion to develop future of COVID-19 vaccines and therapeutics
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
Alberta Innovates invested $13.6 million to strengthen Alberta’s technology sector
On Aug. 22, 2023, Alberta Innovates announced that more than $13.6 million will go to 19 partners, across…
U.S. FDA approved ABRYSVO, Pfizer’s vaccine for prevention of RSV in infants through active immunization of pregnant Individuals
On Aug. 21, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
Maryland Department of Health announced positive case of locally acquired malaria
On Aug. 18, 2023, the Maryland Department of Health has confirmed and reported a positive case of locally…
National Institutes of Health established Maternal Health Research Centers of Excellence
On Aug. 17, 2023, the National Institutes of Health announced it had awarded $24 million in first-year funding…
CPRIT awarded more than $49 million to Texas institutions for cancer research and prevention
On Aug. 16, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved over…
Pig kidney xenotransplantation performed optimally after 32 days in human body
On Aug. 16, 2023, surgeons at NYU Langone Health announed they had transplanted a genetically engineered pig kidney…
NIH unveiled comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries
On Aug. 14, 2023, the National Institute of Health announced that it had released a comprehensive dataset that…
COVID-19 vaccination and boosting during pregnancy benefits pregnant women and newborns
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
WHO issued standing recommendations for COVID including Omicron EG.5 variant risk
On Aug. 9, 2023, the World Health Organization (WHO) released standing recommendations for battling COVID-19 and released an…
Biotechnology | Medicine | NIH | Therapeutics
Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
On Aug. 7, 2023, a National Institute of Health supported study found that in 2021, an estimated 2.5…
Biotechnology | Disease | HIV | Influenza | Measles | Medicine | Plague | Polio | Therapeutics | Vaccine
The United Kingdom announced the Vaccine Development and Evaluation Centre
On Aug. 7, 2023, the United Kingdom Health and Security Agency announced the Vaccine Development and Evaluation Centre…
U.S. FDA approved ZURZUVAE (zuranolone), the First and only oral treatment for Women with postpartum depression
On Aug. 4, 2023, Biogen and Sage Therapeutics announced that the U.S. Food and Drug Administration (FDA) had…
CDC reported two human infections with swine flu viruses
On Aug. 4, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported the first two U.S….
U.S. FDA approved Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for use in children 12 months of age and older
On Aug. 3, 2023, Merck announced that the U.S. Food and Drug Administration (FDA) had approved an expanded…
Finnish Food Authority ordered all minks be put down at fur farms with diagnosed avian influenza infections
On Aug. 1, 2023, the Finnish Food Authority specified the euthanasia criteria for fur animals infected with avian…
USDA, Washington State University break ground on state-of-the-art agricultural research Facility
On Aug. 1, 2023, the U.S. Dept of Agriculture (USDA) announced the groundbreaking of a new Plant Sciences…
Henrietta Lacks’ family settled lawsuit with biotech company that used her cells without consent
On Aug. 1, 2023, more than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical…
BD received 510(k) clearance for COVID-19, influenza A/B, RSV molecular combination test
On Aug. 1, 2023, BD announced that the U.S. Food and Drug Administration (FDA) 510(k) had provided clearance…
Emergent BioSolutions awarded 10-Year BARDA contract valued at $704 million for Ebanga treatment for Ebola
On Jul. 31, 2023, Emergent BioSolutions announced that it was awarded a 10-year contract by the Biomedical Advanced…
Scientists developed breath test that rapidly detects COVID-19 virus
On Jul. 31, 2023, scientists at Washington University in St. Louis have developed a breath test that quickly…
U.S. Department of Health and Human Services announced the Formation of the Office of Long COVID Research
On Jul. 31, 2023, the U.S. Department of Health and Human Services announced the formation of the Office…
Biotechnology | FDA | Vaccine
U.S. FDA approved Ervebo first U.S.-licensed vaccine for prevention of Ebola virus disease
On Jul. 28, 2023, the U.S. Food and Drug Administration (FDA) approved Merck’s Ervebo, a vaccine for the…
Feinstein Institutes researchers first to use double neural bypass to restore movement in man living with quadriplegia
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Healthﾒs…
U.S. FDA approved second OTC Naloxone nasal spray product
On Jul. 28, 2023, the U.S. FDA approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter…